2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
DateTitle  
02/09/17Apricus Biosciences Receives Positive Nasdaq Listing Determination
SAN DIEGO, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that on February 8, 2017, the Company was notified that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for continued listing on Nasdaq pursuant to an extension through May 30, 2017, by which date the Company must evidence full compliance with all applicable criteria for continued ... 
 Printer Friendly Version
02/08/17Apricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference
SAN DIEGO, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will present at the 19th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2017, at 9:00 a.m. Eastern Time.  The conference will be held at The Waldorf Astoria, New York, NY.  Mr. Pascoe will provide an update on Vitaros®, the Company's topical t... 
 Printer Friendly Version
01/18/17Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico
Ferring Plans to Launch in Mexico and Argentina During the Second Quarter 2017 SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Mexico has granted Apricus’ commercialization partner, Ferring Pharmaceuticals, market approval for Vitaros®, an on-demand topical cream indicated for the treatment of patients with erectile dysfunction. This is the twen... 
 Printer Friendly Version
01/03/17Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Mary Naggs has been promoted to Vice President, General Counsel, effective January 1, 2017.  Ms. Naggs will report directly to Richard Pascoe, the Company’s Chief Executive Officer, and serve as a member of the Company’s executive team. Ms. Naggs advances from the position of Associate General Couns... 
 Printer Friendly Version